STRATA Skin Sciences to Present at Upcoming October Conferences
HORSHAM, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to...
Month: September 2023
LifeMD to Participate in Two Investor Conferences in October
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services,...
BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry
Preliminary Research on Late Life Depression and Accelerated Depression Treatment Protocol will be FeaturedBURLINGTON, Mass. and JERUSALEM, Sept. 27, 2023...
gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)
Two prospective, peer reviewed trials demonstrate the symptomatic benefit of gammaCore in patients with PTSDROCKAWAY, N.J., Sept. 27, 2023 (GLOBE...
Streamline Health® Announces New RevID™ Contract With Georgia-Based Healthcare Provider
68-bed Georgia-based healthcare provider selected RevID’s automated charge reconciliation to help eliminate revenue leakageClosed in collaboration with large channel partnerAtlanta,...
Cidara Therapeutics to Present New Data on Novel drug-Fc conjugate CD388 at IDWeek 2023
SAN DIEGO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
Vaccinex to Present Update on PDAC/Pepinemab Study; New ActivMAb® Application
Phase 1b/2 pepinemab/PDAC study update to be presented on September 29 at special AACR meeting New ActivMAb® application to be...
The Dream Machine: When Fiction Exceeds Reality
THE DREAM MACHINE A book for Children living with chronic or rare illnesses (caption) MONTREAL, Sept. 27, 2023 (GLOBE NEWSWIRE)...
Indaptus Therapeutics to Present at the LD Micro Main Event XVI
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief...
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
Following the reverse share split, the Company will have approximately 521,090 Ordinary Shares issued and outstanding TEL AVIV, Israel, Sept....
PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KETARX™ (Ketamine)
FDA assigns GDUFA goal date of April 29, 2024 Milestone builds upon PharmaTher’s commitment toward unlocking the potential of ketamine...
Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron’s Libtayo®
- Eleven patients enrolled overall in trial to date, with enrollment progressing faster than anticipated - - Monotherapy arm has...
ZyVersa Therapeutics’ CEO, Stephen C. Glover to Participate in Panel at the BioFlorida Conference Discussing Inflammation and its Impact on Numerous Diseases
Mr. Glover will also serve as a judge in BioPitch competition for life science companies seeking seed and early-stage investment.ZyVersa...
Emerging Markets Report: Smart Minds, Smart Money
Vinergy Developing and Investing in the Next Generation of A.I. Driven Health CareAn Emerging Markets Sponsored Commentary ORLANDO, Fla, Sept....
Revolutionizing Surgical Training: CSurgeries Partners with Sheltowee Network for Expansive Relaunch
LOUISVILLE, Ky., Sept. 27, 2023 (GLOBE NEWSWIRE) -- via IBN - CSurgeries, a top-tier online surgical video journal, is proud...
Augmedix Announces New AI Medical Documentation Product, Augmedix Go, a Clinician-Controlled Mobile App
Committed to progressing scalable AI technologies, Augmedix’s newest fully automated product is adaptable to serve acute and ambulatory care settingsSAN...
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced...
Matinas BioPharma to Feature MAT2203 in a Pipeline Presentation at IDWeek
BEDMINSTER, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining...
Sibannac, Inc. Signs Heads of Terms Agreement with Allstar Health-Tyme Cannabis to Enter the Canadian Cannabis Retail Market
Scottsdale, Arizona--(Newsfile Corp. - September 27, 2023) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the...
Therma Bright Announces Amendments to InStatin & InVixa Acquisitions
InStatin & InVixa Are Developing Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)Toronto, Ontario--(Newsfile Corp. - September...